TCR immunoconjugates for targeting cancer cells

被引：0
|
作者：
Li, Y. [1 ]
Lissin, N. [1 ]
Molloy, P. [1 ]
Moysey, R. [1 ]
Dunn, S. [1 ]
Baston, E. [1 ]
Mahon, T. [1 ]
Sutton, D. [1 ]
Brewer, J. [1 ]
Jakobsen, B. [1 ]
机构：
[1] Avidex Ltd, Abingdon OX14 4RX, Oxon, England
来源：
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 2006年 / 21卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [31] Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1
    Marcinkowski, Bridget
    Stevanovic, Sanja
    Heiman, Sarah R.
    Norberg, Scott M.
    Serna, Carylinda
    Jin, Benjamin
    Gkitsas, Nikolaos
    Kadakia, Tejas
    Warner, Andrew
    Davis, Jeremy L.
    Rooper, Lisa
    Hinrichs, Christian S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [32] TCRγδ cells in HPV-associated cervical cancer
    Renoux, V
    De Leval, L.
    Waroux, O.
    Roncarati, P.
    Dortu, E.
    Cathy, R.
    Arafa, M.
    Boniver, J.
    Delvenne, P.
    Jacobs, N.
    ACTA CLINICA BELGICA, 2008, 63 (01): : 57 - 57
  • [33] Cytotoxicity of selenium trastuzumab and bevacizumab immunoconjugates against triple negative breast cancer cells
    Khandelwal, Soni
    Gollahon, Lauren
    Spallholz, Julian
    Boylan, Mallory
    Garcia-Hernandez, Maria Del Mar
    CANCER RESEARCH, 2017, 77
  • [34] Eukaryotic expression vectors and immunoconjugates for cancer therapy
    E. M. Glinka
    E. F. Edelweiss
    S. M. Deyev
    Biochemistry (Moscow), 2006, 71 : 597 - 606
  • [35] Preclinical evaluation of targeting PRAME with TCR mimic CAR T cells in AML
    Kirkey, Danielle
    Robinson, Leila
    Hylkema, Tiffany
    Loeb, Anisha
    Castro, Sommer
    Tang, Thao
    Ries, Rhonda E.
    Mckay, Cyd
    Root, Christina
    Pardo, Laura
    Loeb, Keith
    Le, Quy
    Meshinchi, Soheil
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] NK cells specifically TCR-dressed to kill cancer cells
    Mensali, Nadia
    Dillard, Pierre
    Hebeisen, Michael
    Lorenz, Susanne
    Theodossiou, Theodossis
    Myhre, Marit Renee
    Fane, Anne
    Gaudernack, Gustav
    Kvalheim, Gunnar
    Myklebust, June Helen
    Inderberg, Else Marit
    Walchli, Sebastien
    EBIOMEDICINE, 2019, 40 : 106 - 117
  • [37] Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
    Dillard, Pierre
    Koksal, Hakan
    Maggadottir, Solrun Melkorka
    Winge-Main, Anna
    Pollmann, Sylvie
    Menard, Mathilde
    Myhre, Marit Renee
    Maelandsmo, Gunhild M.
    Florenes, Vivi Ann
    Gaudernack, Gustav
    Kvalheim, Gunnar
    Walchli, Sebastien
    Inderberg, Else Marit
    MOLECULAR THERAPY, 2021, 29 (03) : 1199 - 1213
  • [38] Development of engineered transgenic TCR targeting SALL4 for cancer immunotherapy
    Ben Khelil, Myriam
    Perchaud, Marie
    Spehner, Laurie
    Asgarov, Kamal
    Bouard, Adeline
    Monnien, Franck
    Vienot, Angelique
    Harari, Alexandre
    Jandus, Camilla
    Kroemer, Marie
    Borg, Christophe
    Loyon, Romain
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 388 - 388
  • [39] Targeting cancer stem cells
    Kvinlaug, Brynn T.
    Huntly, Brain J. P.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (07) : 915 - 927
  • [40] Targeting aneuploid cancer cells
    Colombo, Riccardo
    Moll, Juergen
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (05) : 595 - 608
12345